Concepedia

Hugh Laverty

HL

9

Publications

661

Citations

9

H-Index

1998

Active since

Affiliations

University of Manchester(Current)

Renovo (United Kingdom)

University of Glasgow

Hugh Laverty is an author at University of Manchester specializing in medicine, data management, and stem cell therapies.

Top concepts

Publications per year

1998–2015

9

Publications

9

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

Mark W. J. Ferguson, Jonathan Duncan, Jeremy S. Bond et al. · The Lancet · 2009 · 296 citations

, , +10

Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity

Daniel J. Antoine, Dominic P. Williams, Anja Kipar et al. · Molecular Medicine · 2010 · 103 citations · Full text

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring

Nick L. Occleston, Sharon O’Kane, Hugh Laverty et al. · Wound Repair and Regeneration · 2011 · 78 citations

Murine CASK Is Disrupted in a Sex-Linked Cleft Palate Mouse Mutant

Hugh Laverty, Joanna B. Wilson · Genomics · 1998 · 69 citations

, , +6

A synthetic gene increases TGFβ3 accumulation by 75‐fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule

Martin F. Gisby, Philip Mellors, Panagiotis Madesis et al. · Plant Biotechnology Journal · 2011 · 43 citations · Full text

Rows per page

1–5 of 9